2-(6-amino-8-hydrazinyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

 化学構造式
3868-34-6
CAS番号.
3868-34-6
化学名:
别名:
英語名:
2-(6-amino-8-hydrazinyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
英語别名:
8-Hydrazinoadenosine;Regadenoson Impurity 56;Adenosine, 8-hydrazinyl-;2-(6-amino-8-hydrazinyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
CBNumber:
CB03213906
化学式:
C10H15N7O4
分子量:
297.27
MOL File:
3868-34-6.mol

2-(6-amino-8-hydrazinyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 物理性質

沸点 :
682.4±65.0 °C(Predicted)
比重(密度) :
2.29±0.1 g/cm3(Predicted)
酸解離定数(Pka):
12?+-.0.70(Predicted)

安全性情報

2-(6-amino-8-hydrazinyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

2-(6-amino-8-hydrazinyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 化学特性,用途語,生産方法

2-(6-amino-8-hydrazinyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 上流と下流の製品情報

原材料

準備製品


2-(6-amino-8-hydrazinyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 生産企業

Global( 12)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
+86-021-61551413 +8618813727289
contact@trustwe.com China 5738 58
BOC Sciences
+16314854226
inquiry@bocsci.com United States 19743 58
NewCan Biotech Limited
+86-0571-86912261 +8613735419629
sales@newcanbio.com China 10026 58
T&W GROUP 021-61551611 13296011611
contact@trustwe.com China 9900 58
Fuyang Ziyi Biological Pharmaceutical Co., Ltd. 19308655899
2677609105@qq.com China 461 58
Zhengzhou Granlen Sciences, ltd. 0371-85513397
info@granlen.com China 1842 58
BOC Sciences 16314854226
inquiry@bocsci.com United States 9713 58
Shanghai meikai technology co., ltd 021-18721550-091 18721550091
yangdong@pharma.com China 4123 58
QUALITY CONTROL SOLUTIONS LTD. 13670046396
ORDERS@QCSRM.COM China 18810 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
cb5@aikonchem.com China 10529 58

  • 3868-34-6
  • 2-(6-amino-8-hydrazinyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
  • 8-Hydrazinoadenosine
  • Adenosine, 8-hydrazinyl-
  • Regadenoson Impurity 56
Copyright 2017 © ChemicalBook. All rights reserved